Case Study: a top 10 pharmaceutical company achieves clearer comparative drug treatment insights with EXL Health

EXL Health helps large pharma company make informed decision on comparative drug treatments

EXL worked with a top 10 pharmaceutical company that needed better insight into patients’ healthcare costs and outcomes for its branded product. The company wanted to compare cost of care and service utilization across its own treatments and competing products, but lacked adjudicated claims data and clear visibility into the costs associated with different patient groups and indications.

EXL Health used advanced analytics to define patient populations by ICD-10 diagnosis codes, segment them into cohorts and treatment periods, and analyze dimensions such as age, gender, location, and timeframe. EXL then calculated total cost of care, utilization, prospective risk, and comorbid conditions, delivering insights on costs, drug utilization, adherence, and chronic condition overlap. The analysis gave the client leverage in payer discussions and supported value-based outcome conversations.